Long-term use of progestogens – getting the balance right: Molecular biology and the endometrium

References

• Gargett C E, Rogers P A. Human endometrial angiogenesis. Reproduction 2001; 121: 181–186
   PubMed Web of Science ®Google Scholar
• Gambino L S, Wreford N G, Bertram J F, Dockery P, Lederman F, Rogers P A. Angiogenesis occurs by vessel elongation in proliferative phase human endometrium. Hum Reprod 2002; 17: 1199–1206
   PubMed Web of Science ®Google Scholar
• Moeller B. Human endometrial angiogenesis. Comprehensive summaries of Uppsala Dissertations from the Faculty of Medicine 1315 [Internet]. Uppsala University, Uppsala 2004, [cited 2007 Aug 18]. Available from: http://www.diva-portal.org/diva/getDocument?urn_nbn_se_uu_diva-3900-1
   Google Scholar
• Critchley H OD. Endometrial effects of progestogens. Gynaecol Forum 2003; 8: 6–10
   Google Scholar
• Smith O PM, Critchley H OD. Progestogen only contraception and endometrial breakthrough bleeding. Angiogenesis 2005; 8: 117–126
   PubMedGoogle Scholar
• Iruela-Arispe M L, Rodriguez-Manzaneque J C, Abu-Jawdeh G. Endometrial endothelial cells express oestrogen and progesterone receptors and exhibit tissue specific response to angiogenic growth factors. Microcirculation 1999; 6: 127–140
   PubMedGoogle Scholar
• Moeller B, Rasmussen C, Lindblom B, Olovsson M. Expression of the angiogenic growth factors VEGF, FGF-2, EGF and their receptors in normal human endometrium during the menstrual cycle. Mol Hum Reprod 2001; 7: 65–72
   PubMedGoogle Scholar
• Popovici R M, Irwin J C, Giaccia A J, Giudice L C. Hypoxia and cAMP stimulate vascular endothelial growth factor (VEGF) in human endometrial stromal cells: potential relevance to menstruation and endometrial regeneration. J Clin Endocrinol Metab 1999; 84: 2245–2248
   PubMed Web of Science ®Google Scholar
• Iruela-Arispe M L, Porter P, Bornstein P, Sage E H. Thrombospodin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest 1996; 97: 403–412
   PubMed Web of Science ®Google Scholar
• Mueller M D, Vigne J L, Pritts E A, Chao V, Dreher E, Taylor R N. Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells. Fertil Steril 2003; 79: 386–392
   PubMedGoogle Scholar
• Smith S K, Abels M H, Kelly R W, Baird D T. Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 1981; 88: 434–442
   PubMedGoogle Scholar
• Tabibzadeh S. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol Hum Reprod 1996; 2: 77–92
   PubMed Web of Science ®Google Scholar
• Livingston M, Fraser I S. Mechanisms of abnormal uterine bleeding. Hum Reprod Update 2002; 8: 60–67
   PubMedGoogle Scholar
• Swiss-Prot database. ExPASy Proteonomics server of the Swiss Institute of Bioinformatics [Internet]. Swiss Institute of Bioinformatics, Basel, [date unknown]–[cited 2007 Feb 22]. Available from: http://expasy.org
   Google Scholar
• Dong J-C, Dong H, Campana A, Bischof P. Matrix metalloproteinases and their specific tissue inhibitors in menstruation. Reproduction 2002; 123: 621–631
   PubMed Web of Science ®Google Scholar
• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Circ Res 2003; 92: 827–839
   PubMed Web of Science ®Google Scholar
• Marbaix E, Kokorine I, Moulin P, Donnez J, Eeckhout Y, Courtoy P J. Menstrual breakdown of human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc Natl Acad Sci U S A 1996; 93: 9120–9125
   PubMed Web of Science ®Google Scholar
• Marbaix E, Donnez J, Courtoy P F, Eeckhout Y. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc Natl Acad Sci U S A 1992; 89: 11789–11793
   PubMed Web of Science ®Google Scholar
• Goffin F, Munaut C, Frankenne F, Perrier D'Hauterive S, Beliard A, Fridman V, Nervo P, Colige A, Foidart J M. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium. Biol Reprod 2003; 69: 976–984
   PubMed Web of Science ®Google Scholar
• Kothapalli R, Buyuksal I, Wu S Q, Chegini N, Tabibzadeh S. Detection of ebaf, a novel human gene of the transforming growth factor β superfamily. J Clin Invest 1997; 99: 2342–2350
   PubMed Web of Science ®Google Scholar
• Cornet P B, Picquet C, Lemoine P, Osteen K G, Bruner-Tran K L, Tabibzadeh S, Courtoy P J, Eeckhout Y, Marbaix E, Henriet P. Regulation and function of LEFTY-A/EBAF in the human endometrium. J Biol Chem 2002; 277: 42496–42504
   PubMedGoogle Scholar
• Cornet P B, Galant C, Eeckhout Y, Courtoy P J, Marbaix E, Henriet P. Regulation of matrix metalloproteinases-9/gelatinase B expression and activation by ovarian steroids and LEFTY-A/endometrial bleeding-associated factor in the human endometrium. J Clin Endocrinol Metab 2005; 90: 1001–1011
   PubMed Web of Science ®Google Scholar
• Tabibzadeh S. Decoding implantation and menstruation: a tale of two opposing signals. Front Biosci 2002; 7: 1475–1486
   Google Scholar
• Jabbour H N, Kelly R W, Fraser H M, Critchley H OD. Endocrine regulation of menstruation. Endocrine Rev 2005; 27: 17–46
   PubMedGoogle Scholar
• Salomonsen L A, Zhang J, Brasted M. Leukocyte networks and human endometrial remodelling. J Reprod Immunol 2002; 57: 95–108
   PubMedGoogle Scholar
• Adelantado J M, Rees M CP, Bernal A L, Turnbull A C. Increased intrauterine prostaglandin E receptors in menorrhagic women. Br J Obstet Gynaecol 1988; 95: 162–165
   PubMedGoogle Scholar
• Song J Y, Markham R, Russel P, Wong T, Young L, Fraser I S. The effect of high-dose, medium- and long-term progestogen exposure on endometrial vessels. Hum Reprod 1995; 10: 797–800
   PubMed Web of Science ®Google Scholar
• Hickey M, Dwarte D, Fraser I S. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding. Hum Reprod 2000; 15: 1509–1514
   PubMed Web of Science ®Google Scholar
• Galant C, Berliere M, Dubois D, Verougstraete J C, Charles A, Lemoine P, Kokorine I, Eeckhout Y, Courtoy P J, Marbaix E. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional bleeding. Am J Pathol 2004; 165: 83–94
   PubMed Web of Science ®Google Scholar
• Galant C, Vekemans M, Lemoine P, Kokorine I, Twagirayezu P, Henriet P, Picquet C, Rigot V, Eeckhout Y, Courtoy P J, et al. Temporal and spatial association of matrix metalloproteinases with focal endometrial breakdown and bleeding upon progestin-only contraception. J Clin Endocrinol Metab 2000; 85: 4827–4834
   PubMed Web of Science ®Google Scholar
• Vincent A J, Zhang J, Östör A, Rogers P A, Affandi B, Kovacs G, Salamonsen L A. Decreased tissue inhibitor of metalloproteinase in the endometrium of women using depot medroxyprogesterone acetate: a role for altered endometrial matrix metalloproteinase/tissue inhibitor of metalloproteinase balance in the pathogenesis of abnormal uterine bleeding?. Hum Reprod 2002; 17: 1189–1198
   PubMed Web of Science ®Google Scholar
• Vincent A J, Salomonsen L A. The role of matrix metalloproteinases and leukocytes in abnormal uterine bleeding associated with progestin-only contraceptives. Hum Reprod 2000; 15(Suppl 4)135–143
   PubMedGoogle Scholar
• Hickey M, Higham J, Sullivan M, Miles L, Fraser I S. Endometrial bleeding in hormone replacement therapy users: preliminary findings regarding the role of matrix metalloproteinase 9 (MMP-9) and tissue inhibitors of MMPs. Fertil Steril 2001; 75: 288–296
   PubMed Web of Science ®Google Scholar
• Hickey M, Pillai G, Higham J M, Sullivan M, Horncastle D, Doherty D, Stamp G. Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding. Hum Reprod 2003; 18: 1100–1106
   PubMed Web of Science ®Google Scholar
• Wahab M, Thompson J, Al-Azzawi F. Effect of different cyclical sequential progestins on endometrial vascularity in postmenopausal women compared with the natural cycle: a morphometric analysis. Hum Reprod 2000; 10: 2075–2081
   Google Scholar
• Archer D F, Navarro F, Leslie S, Mirkin S. Effect of levonorgestrel, medroxyprogesterone acetate, norethindrone and 17β oestradiol on vascular endothelial growth factor isomers 121 and 165. Fertil Steril 2004; 81: 165–170
   PubMed Web of Science ®Google Scholar
• Mirkin S, Navarro F, Archer D F. Hormone therapy and endometrial angiogenesis. Climacteric 2003; 6: 273–277
   PubMed Web of Science ®Google Scholar
• Schindler A E, Campagnoli C, Druckmann R, Huber J, Pasqualini J R, Schweppe K W, Thijssen J H. Classification and pharmacology of progestins. Maturitas 2003; 46(Suppl 1)S7–S16
   PubMed Web of Science ®Google Scholar
• Aplin J D, Kimber S J. Trophoblast–uterine interactions at implantation. Reprod Biol Endocrinol 2004; 2: 48
   PubMedGoogle Scholar
• Salomonsen L A. Role of proteases in implantation. Rev Reprod 1999; 4: 11–22
   PubMedGoogle Scholar
• Druckmann R, Druckmann M A. Progesterone and the immunology of pregnancy. J Steroid Biochem Mol Biol 2005; 97: 389–396
   PubMed Web of Science ®Google Scholar
• Porstmann J, Arck P C. PIBF – Schlüssel zu einer erfolgreichen Schwangerschaft?. J Fertil Reprod 2005; 15: 7–11
   Google Scholar
• Walch K, Hefler L, Nagele F. Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial. J Matern Fetal Neonatal Med 2005; 18: 265–269
   PubMed Web of Science ®Google Scholar
• Hapgood J P, Koubovec D, Louw A, Africander D. Not all progestins are the same: implications for usage. Trends Pharmacol Sci 2004; 25: 554–557
   PubMedGoogle Scholar
• Chwalisz K, Perez M C, DeManno D, Winkel C, Schubert G, Elger W. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev 2005; 26: 423–438
   PubMed Web of Science ®Google Scholar